Specific inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells

P844

  • Burger, M.
  • Hartmann, T.
  • Rawluk, J.
  • Fujii, N.
  • Kipps, T.
  • Burger, J.

  • Freiburg, D; Kyoto, J; San Diego, USA

Onkologie 26:p 167, October 2003.
Copyright © 2003 S. Karger AG, Basel
View full text|Download PDF